Managing VTE: A concise review of NOACs

Managing VTE: A concise review of NOACs

Haematology
A badge with ribbon in color black Point(s): 1 | An analog clock in color black 15 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 23 Apr 2022 

Overview

NEW!

Venous thromboembolism (VTE) is the third most common cardiovascular disease after myocardial infarction and stroke. The goal of this learning activity is to provide doctors with a comprehensive review on the role of non-vitamin K antagonist oral anticoagulants (NOACs) in the management of VTE. Upon completing this module, participants will have a better understanding of the epidemiology and burden of VTE, risk assessment and prophylaxis, anticoagulant therapy for VTE and the efficacy and safety profile of NOACs in the acute and extended treatment of VTE. 

CPD reviewer:
Dr Tan Jiunn Liang

MD(UPM),MMed(Int.Med) (UM)

Consultant Chest Physician

University Malaya Medical Centre (UMMC)

Kuala Lumpur, Malaysia

• Lecture
• Q&A session

Who should participate:
• Doctors

NOTE :
Please watch the video before attempting the assessment questions.

Terms & Conditions: 
■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point. 
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points

To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.

Sponsored by:

Pfizer_logo.jpg